{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:36:39Z","timestamp":1780472199253,"version":"3.54.1"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2009,7,31]],"date-time":"2009-07-31T00:00:00Z","timestamp":1248998400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1038\/eye.2009.203","type":"journal-article","created":{"date-parts":[[2009,7,31]],"date-time":"2009-07-31T16:46:10Z","timestamp":1249058770000},"page":"1868-1870","source":"Crossref","is-referenced-by-count":55,"title":["Switching biologic agents for uveitis"],"prefix":"10.1038","volume":"23","author":[{"given":"N","family":"Dhingra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A D","family":"Dick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,7,31]]},"reference":[{"issue":"11","key":"BFeye2009203_CR1","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1136\/bjo.83.11.1230","volume":"83","author":"AD Dick","year":"1999","unstructured":"Dick AD, Isaacs JD . Immunomodulation of autoimmune responses with monoclonal antibodies and immunoadhesins: treatment of ocular inflammatory disease in the next millennium. Br J Ophthalmol 1999; 83 (11): 1230\u20131234.","journal-title":"Br J Ophthalmol"},{"key":"BFeye2009203_CR2","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/ICU.0b013e3282f03d42","volume":"18","author":"F Imrie","year":"2007","unstructured":"Imrie F, Dick AD . Biologics in the treatment of uveitis. Curr Opin Ophthalmol 2007; 18: 481\u2013486.","journal-title":"Curr Opin Ophthalmol"},{"key":"BFeye2009203_CR3","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1093\/rheumatology\/ken127","volume":"47","author":"KL Hyrich","year":"2008","unstructured":"Hyrich KL, Lunt M, Dixon WG, Watson K D, Symmons DPM . Effects of switching between anti-TNF therapies on HAQ response in patients who do not respond to their first anti-TNF drug. Rheumatology 2008; 47: 1000\u20131005.","journal-title":"Rheumatology"},{"key":"BFeye2009203_CR4","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1136\/ard.2007.069872","volume":"66","author":"RF van Vollenhoven","year":"2007","unstructured":"van Vollenhoven RF . Switching between anti-tumour necrosis factors: trying to get a handle on a complex issue. Ann Rheum Dis 2007; 66: 849\u2013851.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"BFeye2009203_CR5","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"DA Jabs","year":"2005","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT . Standardization of uveitis nomenclature for reporting clinical data. Results of First International Workshop. Am J Ophthalmol 2005; 140 (3): 509\u2013516.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"BFeye2009203_CR6","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S0161-6420(85)34001-0","volume":"92","author":"RB Nussenblatt","year":"1985","unstructured":"Nussenblatt RB, Palestine AG, Chan CC, Roberge F . Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology 1985; 92 (4): 467\u2013471.","journal-title":"Ophthalmology"},{"key":"BFeye2009203_CR7","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/sj.eye.6702352","volume":"21","author":"B Mushtaq","year":"2007","unstructured":"Mushtaq B, Saeed T, Situnayake RD, Murray PI . Adalimumab for sight-threatening uveitis in Behcet's disease. Eye 2007; 21: 824\u2013825.","journal-title":"Eye"},{"issue":"5","key":"BFeye2009203_CR8","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1136\/ard.2008.092585","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, R\u00f8devand E, Holck P, Vanhoof J, Kron M, Kary S, Kupper H . Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study. Ann Rheum Dis 2009; 68 (5): 696\u2013701.","journal-title":"Ann Rheum Dis"},{"key":"BFeye2009203_CR9","first-page":"1021","volume":"31","author":"B Haraoui","year":"2004","unstructured":"Haraoui B . Is there a rationale for switching from one anti-tumor necrosis factor agent to another? J Rheumatol 2004; 31: 1021\u20131022.","journal-title":"J Rheumatol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/eye2009203.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye2009203","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye2009203.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:08:41Z","timestamp":1684429721000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/eye2009203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,31]]},"references-count":9,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["BFeye2009203"],"URL":"https:\/\/doi.org\/10.1038\/eye.2009.203","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,31]]}}}